UCB Named a Metro Atlanta Top Workplace

Global biopharmaceutical company UCB has been named a "Metro Atlanta Top Workplace 2026" by Axios. The recognition is based on feedback collected from the company's employees.

The award comes as UCB is expanding its Georgia presence with a $2 billion investment in a new biomanufacturing campus. This facility is projected to create more than 330 jobs in the region.

The significant investment highlights UCB's commitment to growth in the Atlanta area and its role in the biopharmaceutical sector. The new campus will bolster the company's manufacturing capabilities to support its global operations.

Top Workplace awards typically recognize companies for their culture, employee engagement, and overall work environment. UCB's inclusion suggests a positive and supportive atmosphere for its workforce.